ADMP - Adamis Pharmaceuticals Corporation (ADMP) CEO Dr. Dennis Carlo on Q4 2021 Results - Earnings Call Transcript

Adamis Pharmaceuticals Corporation (ADMP) Q4 2021 Earnings Conference Call March 31, 2022 5:00 PM ET Company Participants Robert Uhl - ICR Westwicke Dr. Dennis Carlo - President, CEO and Director David Benedicto - CFO Dr. Ron Moss - Chief Medical Officer David Marguglio - Senior VP, Chief Business Officer and Director Presentation Operator Greetings, and welcome to Adamis Pharmaceuticals Full Year 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. The question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Robert Uhl, with ICR Westwicke. Robert Uhl Thank you, operator, and good afternoon, everyone, and welcome to the Adamis Pharmaceuticals 2021 financial results and corporate update conference call. Thank you for joining us today for the update, and welcome

For further details see:

Adamis Pharmaceuticals Corporation (ADMP) CEO Dr. Dennis Carlo on Q4 2021 Results - Earnings Call Transcript